Skip to content

Anaesthesia in cases of narrow trachea

SAFETY AND EFFICACY OF TOTAL INTRAVENOUS ANAESTHESIA (TIVA) WITH SPONTANEOUS VENTILATION AND TOPICAL ANAESTHETIC SUPPLEMENTATION FOR RIGID BRONCHOSCOPY IN CASES OF LARYNGO-TRACHEAL STENOSIS

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013983
Enrollment
50
Registered
2018-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1.All adult patients ASA Grade I to III. 2.Diagnostic and therapeutic cases of Laryngo-tracheal stenosis Health Condition 2: J955- Postprocedural subglottic stenosis

Interventions

None listed

Sponsors

Lokmanya Tilak Municipal Medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All adult patients ASA Grade I to III. 2.Either Sex. 3.Consenting patients 4.Diagnostic and therapeutic cases of Laryngo-tracheal stenosis

Exclusion criteria

Exclusion criteria: 1.ASA IV. 2.Unwilling to give consent. 3.Known allergy to local anesthesia drugs. 4.Known allergy to dexmedetomidine, propofol.

Design outcomes

Primary

MeasureTime frame
1)Safety Outcome-It is judged by Incidence of desaturation events. 2)Efficacy Outcome- Efficacy of the technique is defined as the ability to complete the procedure under TIVA with spontaneous ventilation without the need of Muscle relaxants and inhalational agents.Timepoint: 1.Baseline. 3.After Loading Dexmed. 3.Post Induction. 4.After Bronchoscopy. 4.Every 5 minutes thereafter.

Secondary

MeasureTime frame
1.To assess haemodynamics, 2.Any events of coughing, bucking, laryngospasm, 3.To assess surgeonâ??s satisfaction. Timepoint: 1.Baseline. 2.After Loading Dexmedetomidine. 3.Post Induction. 4.After Bronchoscopy. 5.Every 5 minutes thereafter.

Countries

India

Contacts

Public ContactDr Devangi Parikh

Department of anesthesia, LTMMC

sdevangi10@gmail.com9820471638

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026